Legal & General Group Plc Invests $9.28 Million in Chemed Corporation $CHE

Legal & General Group Plc purchased a new stake in shares of Chemed Corporation (NYSE:CHE) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 19,927 shares of the company’s stock, valued at approximately $9,281,000.

A number of other institutional investors and hedge funds have also modified their holdings of the business. Northwestern Mutual Wealth Management Co. lifted its stake in Chemed by 2,444,879.3% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 5,550,103 shares of the company’s stock worth $2,374,667,000 after acquiring an additional 5,549,876 shares in the last quarter. BlackRock Inc. purchased a new position in Chemed during the 2nd quarter valued at about $691,290,000. JPMorgan Chase & Co. grew its stake in Chemed by 4.4% during the 4th quarter. JPMorgan Chase & Co. now owns 521,900 shares of the company’s stock valued at $223,301,000 after acquiring an additional 21,932 shares in the last quarter. AQR Capital Management LLC increased its holdings in shares of Chemed by 89.2% in the 4th quarter. AQR Capital Management LLC now owns 325,579 shares of the company’s stock valued at $139,302,000 after purchasing an additional 153,469 shares during the period. Finally, TD Asset Management Inc increased its holdings in shares of Chemed by 7.5% in the 4th quarter. TD Asset Management Inc now owns 324,546 shares of the company’s stock valued at $138,860,000 after purchasing an additional 22,715 shares during the period. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Insider Buying and Selling at Chemed

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the firm’s stock in a transaction on Friday, August 21st. The shares were sold at an average price of $541.16, for a total transaction of $1,082,320.00. Following the transaction, the chief executive officer owned 70,418 shares in the company, valued at approximately $38,107,404.88. This trade represents a 2.76% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Spencer S. Lee sold 1,000 shares of the firm’s stock in a transaction on Friday, August 21st. The shares were sold at an average price of $541.04, for a total transaction of $541,040.00. Following the transaction, the executive vice president owned 13,912 shares in the company, valued at $7,526,948.48. This represents a 6.71% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 6,537 shares of company stock valued at $3,406,014. 3.33% of the stock is currently owned by insiders.

Chemed Stock Down 0.5%

CHE opened at $515.96 on Wednesday. Chemed Corporation has a fifty-two week low of $365.20 and a fifty-two week high of $557.00. The business has a 50-day moving average of $512.52 and a 200-day moving average of $450.53. The company has a debt-to-equity ratio of 0.17, a current ratio of 0.91 and a quick ratio of 0.89. The company has a market capitalization of $6.74 billion, a PE ratio of 25.91, a price-to-earnings-growth ratio of 1.96 and a beta of 0.51.

Chemed (NYSE:CHE) last announced its quarterly earnings results on Tuesday, July 28th. The company reported $6.06 EPS for the quarter, beating the consensus estimate of $5.60 by $0.46. The business had revenue of $673.25 million during the quarter, compared to analysts’ expectations of $665.04 million. Chemed had a return on equity of 31.77% and a net margin of 10.60%.The firm’s quarterly revenue was up 8.8% compared to the same quarter last year. During the same quarter in the previous year, the business posted $4.27 EPS. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. Equities research analysts forecast that Chemed Corporation will post 23.18 EPS for the current fiscal year.

Chemed Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, September 3rd. Shareholders of record on Monday, August 17th will be paid a $0.70 dividend. This represents a $2.80 dividend on an annualized basis and a yield of 0.5%. This is a boost from Chemed’s previous quarterly dividend of $0.60. The ex-dividend date is Monday, August 17th. Chemed’s dividend payout ratio is presently 14.06%.

Wall Street Analysts Forecast Growth

CHE has been the subject of several research reports. Wall Street Zen upgraded shares of Chemed from a “hold” rating to a “strong-buy” rating in a report on Saturday, August 1st. Oppenheimer upped their price objective on shares of Chemed from $500.00 to $590.00 and gave the company an “outperform” rating in a research note on Friday, July 31st. Weiss Ratings upgraded shares of Chemed from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, July 17th. Royal Bank Of Canada lifted their target price on shares of Chemed from $436.00 to $548.00 and gave the company a “sector perform” rating in a research note on Thursday, July 30th. Finally, Bank of America restated a “neutral” rating on shares of Chemed in a report on Wednesday, July 29th. One investment analyst has rated the stock with a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $530.75.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.